To further our knowledge of MPL mRNA expression, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and microarray analysis were performed on tumor cell lines and in tumor samples from renal cell carcinomas, prostate cancers, lymphomas, colon cancers, and sarcomas. This evidence concerns the gene MPL and prostate carcinoma.